@article {Ogasawara2022.04.25.22274179, author = {Masashi Ogasawara and Nobuyuki Eura and Aritoshi Iida and Theerawat Kumutpongpanich and Narihiro Minami and Ikuya Nonaka and Shinichiro Hayashi and Satoru Noguchi and Ichizo Nishino}, title = {Intra-myonuclear inclusions are diagnostic of oculopharyngeal muscular dystrophy}, elocation-id = {2022.04.25.22274179}, year = {2022}, doi = {10.1101/2022.04.25.22274179}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The pathologies of oculopharyngeal muscular dystrophy (OPMD) and oculopharyngodistal myopathy (OPDM) are indistinguishable. We found that p62-positive intra-nuclear inclusions (INIs) in myonuclei (myo-INIs) were significantly more frequent in OPMD (11.4 {\textpm} 4.1\%, range 5.0{\textendash} 17.5\%) than in OPDM and other rimmed vacuolar myopathies (RVMs) (1{\textendash}2\% on average, range 0.0{\textendash}3.5\%, p\<0.0001). In contrast, INIs in nonmuscle cells (nonmuscle-INIs) were present in OPDM, but absent in other RVMs, including OPMD. These results indicate that OPMD can be differentiated from OPDM and other RVMs by the frequent presence of myo-INIs (>=5\%) and the absence of nonmuscle-INIs in muscle pathology.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported partly by the Intramural Research Grant (2-5) for Neurological and Psychiatric Disorders of NCNP and AMED under Grant Number JP21ek0109490h0002.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:All patients provided informed consent for using their samples for research after the diagnosis. This study was approved by the ethical committees of the National Center of Neurology and Psychiatry (A2019-123).I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors}, URL = {https://www.medrxiv.org/content/early/2022/04/27/2022.04.25.22274179}, eprint = {https://www.medrxiv.org/content/early/2022/04/27/2022.04.25.22274179.full.pdf}, journal = {medRxiv} }